Serina Therapeutics, Inc. logo

Serina Therapeutics, Inc.

Canonical company identity and public leadership record.

NYSE: SERUS

  • Source reported. 21 claims from 2 sources.
  • Not claimed by the company.
  • Eval: not assessed.
Board
12 directorsAlpha calculation. Published seats
Evidence
2 sources21 published claims
Last reviewed
Freshness: current
Open conflicts
0None open
Alpha EvalNot assessed. No Eval is published for this company.

Leadership

4 claims
Leadership
PersonRoleSinceStatusEvidence
Gregory S. CurhanChief Financial OfficerCurrentSource reportedE3

Stated in the record as Gregory S. Curhan: Chief Financial Officer

Claim ID alpha:claim:company:6fec4b5b-d292-417a-8396-2aad24c2fd4a:leadership_role:17

Report an error
Randall Moreadith, M.D., Ph.D.Chief Development OfficerCurrentSource reportedE4

Stated in the record as Randall Moreadith, M.D., Ph.D.: Chief Development Officer

Claim ID alpha:claim:company:6fec4b5b-d292-417a-8396-2aad24c2fd4a:leadership_role:18

Report an error
Srini Tenjarla, Ph.D.Chief Technical Operations OfficerCurrentSource reportedE5

Stated in the record as Srini Tenjarla, Ph.D.: Chief Technical Operations Officer

Claim ID alpha:claim:company:6fec4b5b-d292-417a-8396-2aad24c2fd4a:leadership_role:19

Report an error
Steve LedgerChief Executive Officer and Class II DirectorCurrentSource reportedE6

Stated in the record as Steve Ledger: Chief Executive Officer and Class II Director

Claim ID alpha:claim:company:6fec4b5b-d292-417a-8396-2aad24c2fd4a:leadership_role:20

Report an error

Board

12 claims
Board of directors
DirectorStatusSinceCommitteesEvidence
Balkrishan GillIndependence not publishedNone publishedSource reportedE2

Stated in the record as Balkrishan Gill: Director

Claim ID alpha:claim:company:6fec4b5b-d292-417a-8396-2aad24c2fd4a:leadership_role:5

Report an error
Gregory H. BaileyIndependence not publishedNone publishedSource reportedE2

Stated in the record as Gregory H. Bailey: Director

Claim ID alpha:claim:company:6fec4b5b-d292-417a-8396-2aad24c2fd4a:leadership_role:6

Report an error
Gregory S. CurhanIndependence not publishedNone publishedSource reportedE2

Stated in the record as Gregory S. Curhan: Director

Claim ID alpha:claim:company:6fec4b5b-d292-417a-8396-2aad24c2fd4a:leadership_role:7

Report an error
J. Milton HarrisIndependence not publishedNone publishedSource reportedE2

Stated in the record as J. Milton Harris: Director

Claim ID alpha:claim:company:6fec4b5b-d292-417a-8396-2aad24c2fd4a:leadership_role:8

Report an error
Jay VenkatesanIndependence not publishedNone publishedSource reportedE2

Stated in the record as Jay Venkatesan: Director

Claim ID alpha:claim:company:6fec4b5b-d292-417a-8396-2aad24c2fd4a:leadership_role:9

Report an error
Karen J. WilsonIndependence not publishedNone publishedSource reportedE2

Stated in the record as Karen J. Wilson: Director

Claim ID alpha:claim:company:6fec4b5b-d292-417a-8396-2aad24c2fd4a:leadership_role:10

Report an error
Randall Moreadith, M.D., Ph.D.Independence not publishedNone publishedSource reportedE2

Stated in the record as Randall Moreadith, M.D., Ph.D.: Director

Claim ID alpha:claim:company:6fec4b5b-d292-417a-8396-2aad24c2fd4a:leadership_role:11

Report an error
Remy GrossIndependence not publishedNone publishedSource reportedE2

Stated in the record as Remy Gross: Director

Claim ID alpha:claim:company:6fec4b5b-d292-417a-8396-2aad24c2fd4a:leadership_role:12

Report an error
Srini Tenjarla, Ph.D.Independence not publishedNone publishedSource reportedE2

Stated in the record as Srini Tenjarla, Ph.D.: Director

Claim ID alpha:claim:company:6fec4b5b-d292-417a-8396-2aad24c2fd4a:leadership_role:13

Report an error
Stephen BrannanIndependence not publishedNone publishedSource reportedE2

Stated in the record as Stephen Brannan: Director

Claim ID alpha:claim:company:6fec4b5b-d292-417a-8396-2aad24c2fd4a:leadership_role:14

Report an error
Steve LedgerIndependence not publishedNone publishedSource reportedE2

Stated in the record as Steve Ledger: Director

Claim ID alpha:claim:company:6fec4b5b-d292-417a-8396-2aad24c2fd4a:leadership_role:15

Report an error
Steven MintzIndependence not publishedNone publishedSource reportedE2

Stated in the record as Steven Mintz: Director

Claim ID alpha:claim:company:6fec4b5b-d292-417a-8396-2aad24c2fd4a:leadership_role:16

Report an error

Authority

1 claim
Authority to act
FactStated valueValid fromEvidence
Principal executive officerSteve Ledger, Chief Executive Officer and Class II Director, from Apr 27, 2026Source reportedE6Same claim as above

Stated in the record as Steve Ledger: Chief Executive Officer and Class II Director

Claim ID alpha:claim:company:6fec4b5b-d292-417a-8396-2aad24c2fd4a:leadership_role:20

Report an error

Not in the public record: who can authorize an agent; ai agents registered by the company; delegations published.

Financial context

2 claims
Financials and market context
FactStated valueEvidence
Security listingSER (NYSE)Source reportedE1

Stated in the record as SER (NYSE)

Claim ID alpha:claim:company:6fec4b5b-d292-417a-8396-2aad24c2fd4a:security_listing:21

Report an error
Security listingSER (NYSE AMERICAN)Source reportedE1

Stated in the record as SER (NYSE AMERICAN)

Claim ID alpha:claim:company:6fec4b5b-d292-417a-8396-2aad24c2fd4a:security_listing:22

Report an error

Other published claims

3 claims
Other published claims
FactStated valueEvidence
Legal nameSerina Therapeutics, Inc.Source reportedE1

Stated in the record as Serina Therapeutics, Inc.

Claim ID alpha:claim:company:6fec4b5b-d292-417a-8396-2aad24c2fd4a:legal_name:1

Report an error
Entity statusPublic listing publishedSource reportedE1

Stated in the record as Public listing published

Claim ID alpha:claim:company:6fec4b5b-d292-417a-8396-2aad24c2fd4a:entity_status:3

Report an error
Published factUSSource reportedE1

Stated in the record as US

Claim ID alpha:claim:company:6fec4b5b-d292-417a-8396-2aad24c2fd4a:published_fact:4

Report an error

Evidence

6 evidence records
Evidence ledger
RefSourceAuthoritySource dateRetrievedRightsCited by
E1Alpha canonical company public projectionCanonical identityOpen webNot recordedRights not recorded, link only5 claims
E2DEF 14A ser-20260427.htmSEC proxyAuthoritative, regulatory filingRights not recorded, link only12 claims
E3SER DEF 14A executive officersSEC filingAuthoritative, regulatory filingRights not recorded, link only1 claim
E4SER DEF 14A executive officersSEC filingAuthoritative, regulatory filingRights not recorded, link only1 claim

No evidence record is pinned or signed yet.

Not yet in this record

These parts of a company record have no published claims yet. That is a coverage state, not a finding about the company. 1 further claim is under review.

  • Committees
  • Control and voting
  • Governance
  • Risk
  • AI oversight
  • Compensation

Index memberships

No current membership is published in Alpha's tracked index universe.

This is not evidence that the company is absent from every market index.

As of 22 Nov 2026. Rights-filtered public evidence only; no redistribution or model training is granted. Only source-backed memberships with an explicit public redistribution basis are returned.

Coverage states the record reports (13)
Corporate structure
Not reviewed. Parent, subsidiary and predecessor structure explains who is governed.
Committees
Not reviewed. Committee mandates show where oversight is delegated.
Ownership
Not reviewed. Ownership and voting power determine who can influence the board.
Financials
Not reviewed. Governance-relevant financial context frames capital and audit decisions.
Compensation
Not reviewed. Pay design shows how incentives are governed.
Governance
Not reviewed. Governing documents and provisions set the rules of the enterprise.
Shareholder governance
Not reviewed. Meeting and vote records show shareholder dissent and support.
Audit
Not reviewed. Auditor, controls and restatements show assurance over reporting.
Legal
Not reviewed. Material legal and regulatory matters show enforcement exposure.
Risk
Not reviewed. Risk ownership links the board, committees, executives and controls.
Cyber
Not reviewed. Cyber and data governance is a disclosed oversight domain.
AI governance
Not reviewed. AI oversight is a differentiated Alpha governance domain.
Markets external
Not reviewed. Auditors, advisors, investors and regulators form the external ecosystem.
Limits of this record (5)
  • Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
  • Only explicitly published canonical company identity and current confirmed public roles are included.
  • Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
  • Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
  • This Company Profile is an identity and evidence record, not an Alpha rating.

History

Version public-1

Published .

  1. Director appointed. Balkrishan Gill seat on Serina Therapeutics, Inc., effective 27 Apr 2026.Effective . Recorded .
  2. Director appointed. Gregory H. Bailey seat on Serina Therapeutics, Inc., effective 27 Apr 2026.Effective . Recorded .
  3. Director appointed. Gregory S. Curhan seat on Serina Therapeutics, Inc., effective 27 Apr 2026.Effective . Recorded .
  4. Director appointed. J. Milton Harris seat on Serina Therapeutics, Inc., effective 27 Apr 2026.Effective . Recorded .
  5. Director appointed. Jay Venkatesan seat on Serina Therapeutics, Inc., effective 27 Apr 2026.Effective . Recorded .
  6. Director appointed. Karen J. Wilson seat on Serina Therapeutics, Inc., effective 27 Apr 2026.Effective . Recorded .
  7. Director appointed. Randall Moreadith, M.D., Ph.D. seat on Serina Therapeutics, Inc., effective 27 Apr 2026.Effective . Recorded .
  8. Director appointed. Remy Gross seat on Serina Therapeutics, Inc., effective 27 Apr 2026.Effective . Recorded .
  9. Director appointed. Srini Tenjarla, Ph.D. seat on Serina Therapeutics, Inc., effective 27 Apr 2026.Effective . Recorded .
  10. Director appointed. Stephen Brannan seat on Serina Therapeutics, Inc., effective 27 Apr 2026.Effective . Recorded .
  11. Director appointed. Steve Ledger seat on Serina Therapeutics, Inc., effective 27 Apr 2026.Effective . Recorded .
  12. Director appointed. Steven Mintz seat on Serina Therapeutics, Inc., effective 27 Apr 2026.Effective . Recorded .
  13. CFO role recorded. Gregory S. Curhan executive of Serina Therapeutics, Inc., effective 27 Apr 2026.Effective . Recorded .
  14. Executive appointed. Randall Moreadith, M.D., Ph.D. executive of Serina Therapeutics, Inc., effective 27 Apr 2026.Effective . Recorded .
  15. Executive appointed. Srini Tenjarla, Ph.D. executive of Serina Therapeutics, Inc., effective 27 Apr 2026.Effective . Recorded .
  16. CEO role recorded. Steve Ledger executive of Serina Therapeutics, Inc., effective 27 Apr 2026.Effective . Recorded .

About this record

Alpha ID
alpha:company:6fec4b5b-d292-417a-8396-2aad24c2fd4a
Version
public-1:ro-d751713988987e9331980363e24189ce
Identity
Not claimed
Evidence
Source reported
Evaluation
Not assessed
Monitoring
Not monitored yet
Authority
Not published
Freshness
Current
Integrity
Not signed yet
Basis
Published company record built from public sources
Never published
Private company data: deployments, authority grants, TrustChecks, receipts, telemetry

The company can claim this record and correct or dispute any claim. Corrections are versioned and the original stays in history. A company's own statements are shown as its own and never replace the cited evidence.